UWA awarded $490,000 to research muscular dystrophy drug

Oct 12, 2018

Researchers at The University of Western Australia have been awarded $490,000 by Duchenne UK to investigate the use of an amino acid commonly used in energy drinks as a treatment for Duchenne Muscular Dystrophy.


Other news

Cookies help us deliver our services. By using our services, you agree to our use of cookies.